464 related articles for article (PubMed ID: 30729696)
1. HLA-B27 prevalence in axial spondyloarthritis patients and in blood donors in a Lebanese population: Results from a nationwide study.
Ziade N; Abi Karam G; Merheb G; Mallak I; Irani L; Alam E; Messaykeh J; Menassa J; Mroue' K; Uthman I; Masri AF; Ghorra P; Witte T; Baraliakos X
Int J Rheum Dis; 2019 Apr; 22(4):708-714. PubMed ID: 30729696
[TBL] [Abstract][Full Text] [Related]
2. Is the current ASAS expert definition of a positive family history useful in identifying axial spondyloarthritis? Results from the SPACE and DESIR cohorts.
Ez-Zaitouni Z; Hilkens A; Gossec L; Berg IJ; Landewé R; Ramonda R; Dougados M; van der Heijde D; van Gaalen F
Arthritis Res Ther; 2017 May; 19(1):118. PubMed ID: 28569222
[TBL] [Abstract][Full Text] [Related]
3. Added Value of Anti-CD74 Autoantibodies in Axial SpondyloArthritis in a Population With Low HLA-B27 Prevalence.
Ziade NR; Mallak I; Merheb G; Ghorra P; Baerlecken N; Witte T; Baraliakos X
Front Immunol; 2019; 10():574. PubMed ID: 30972069
[TBL] [Abstract][Full Text] [Related]
4. HLA B27 antigen in Middle Eastern and Arab countries: systematic review of the strength of association with axial spondyloarthritis and methodological gaps.
Ziade NR
BMC Musculoskelet Disord; 2017 Jun; 18(1):280. PubMed ID: 28662723
[TBL] [Abstract][Full Text] [Related]
5. Geographical prevalence of family history in patients with axial spondyloarthritis and its association with HLA-B27 in the ASAS-PerSpA study.
Boel A; van Lunteren M; López-Medina C; Sieper J; van der Heijde D; van Gaalen FA
RMD Open; 2022 Mar; 8(1):. PubMed ID: 35301267
[TBL] [Abstract][Full Text] [Related]
6. Analysis of HLA-B15 and HLA-B27 in spondyloarthritis with peripheral and axial clinical patterns.
Londono J; Santos AM; Peña P; Calvo E; Espinosa LR; Reveille JD; Vargas-Alarcon G; Jaramillo CA; Valle-Oñate R; Avila M; Romero C; Medina JF
BMJ Open; 2015 Nov; 5(11):e009092. PubMed ID: 26560062
[TBL] [Abstract][Full Text] [Related]
7. High prevalence of anti-CD74 antibodies specific for the HLA class II-associated invariant chain peptide (CLIP) in patients with axial spondyloarthritis.
Baraliakos X; Baerlecken N; Witte T; Heldmann F; Braun J
Ann Rheum Dis; 2014 Jun; 73(6):1079-82. PubMed ID: 23644552
[TBL] [Abstract][Full Text] [Related]
8. Is a positive family history of spondyloarthritis relevant for diagnosing axial spondyloarthritis once HLA-B27 status is known?
van Lunteren M; van der Heijde D; Sepriano A; Berg IJ; Dougados M; Gossec L; Jacobsson L; Ramonda R; Rudwaleit M; Sieper J; Landewé R; van Gaalen FA
Rheumatology (Oxford); 2019 Sep; 58(9):1649-1654. PubMed ID: 30938446
[TBL] [Abstract][Full Text] [Related]
9. Sensitivity and Specificity of Autoantibodies Against CD74 in Nonradiographic Axial Spondyloarthritis.
Riechers E; Baerlecken N; Baraliakos X; Achilles-Mehr Bakhsh K; Aries P; Bannert B; Becker K; Brandt-Jürgens J; Braun J; Ehrenstein B; Euler HH; Fleck M; Hein R; Karberg K; Köhler L; Matthias T; Max R; Melzer A; Meyer-Olson D; Rech J; Rockwitz K; Rudwaleit M; Schmidt RE; Schweikhard E; Sieper J; Stille C; von Hinüber U; Wagener P; Weidemann HF; Zinke S; Witte T
Arthritis Rheumatol; 2019 May; 71(5):729-735. PubMed ID: 30418704
[TBL] [Abstract][Full Text] [Related]
10. Do ethnicity, degree of family relationship, and the spondyloarthritis subtype in affected relatives influence the association between a positive family history for spondyloarthritis and HLA-B27 carriership? Results from the worldwide ASAS cohort.
van Lunteren M; Sepriano A; Landewé R; Sieper J; Rudwaleit M; van der Heijde D; van Gaalen F
Arthritis Res Ther; 2018 Aug; 20(1):166. PubMed ID: 30075809
[TBL] [Abstract][Full Text] [Related]
11. The Frequency of HLA-B27 in a Colombian Population with Signs of Spondyloarthritis.
Romero-Sanchez C; Chila-Moreno L; Gómez A; Casas G MC; Bautista-Molano W; Briceño I; Rueda JC; De Avila J; Londono J; Valle-Onate R
Curr Rheumatol Rev; 2018; 14(3):246-250. PubMed ID: 28356051
[TBL] [Abstract][Full Text] [Related]
12. Assessment of SpondyloArthritis International Society criteria for axial spondyloarthritis in chronic back pain patients with a high prevalence of HLA-B27.
Bakland G; Alsing R; Singh K; Nossent JC
Arthritis Care Res (Hoboken); 2013 Mar; 65(3):448-53. PubMed ID: 22833469
[TBL] [Abstract][Full Text] [Related]
13. Percentage of patients with spondyloarthritis in patients referred because of chronic back pain and performance of classification criteria: experience from the Spondyloarthritis Caught Early (SPACE) cohort.
van den Berg R; de Hooge M; van Gaalen F; Reijnierse M; Huizinga T; van der Heijde D
Rheumatology (Oxford); 2013 Aug; 52(8):1492-9. PubMed ID: 23650623
[TBL] [Abstract][Full Text] [Related]
14. The Role of HLA-B27 in Argentinian Axial Spondyloarthritis Patients.
García-Salinas R; Ruta S; Chichande JT; Magri S
J Clin Rheumatol; 2022 Mar; 28(2):e619-e622. PubMed ID: 34145202
[TBL] [Abstract][Full Text] [Related]
15. Optimizing the identification of patients with axial spondyloarthritis in primary care--the case for a two-step strategy combining the most relevant clinical items with HLA B27.
Braun A; Gnann H; Saracbasi E; Grifka J; Kiltz U; Letschert K; Braun J
Rheumatology (Oxford); 2013 Aug; 52(8):1418-24. PubMed ID: 23559574
[TBL] [Abstract][Full Text] [Related]
16. Ankylosing Spondylitis versus Nonradiographic Axial Spondyloarthritis: Comparison of Tumor Necrosis Factor Inhibitor Effectiveness and Effect of HLA-B27 Status. An Observational Cohort Study from the Nationwide DANBIO Registry.
Glintborg B; Sørensen IJ; Østergaard M; Dreyer L; Mohamoud AA; Krogh NS; Hendricks O; Andersen LS; Raun JL; Kowalski MR; Danielsen L; Pelck R; Nordin H; Pedersen JK; Kraus DG; Christensen SR; Hansen IM; Esbesen J; Schlemmer A; Loft AG; Al Chaer N; Salomonsen L; Hetland ML
J Rheumatol; 2017 Jan; 44(1):59-69. PubMed ID: 27909080
[TBL] [Abstract][Full Text] [Related]
17. Clinical and Imaging Signs of Spondyloarthritis in First-Degree Relatives of HLA-B27-Positive Ankylosing Spondylitis Patients: The Pre-Spondyloarthritis (Pre-SpA) Cohort Study.
Turina MC; de Winter JJ; Paramarta JE; Gamala M; Yeremenko N; Nabibux MN; Landewé R; Baeten DL
Arthritis Rheumatol; 2016 Oct; 68(10):2444-55. PubMed ID: 27214232
[TBL] [Abstract][Full Text] [Related]
18. The clinical utility of human leucocyte antigen B27 in axial spondyloarthritis.
Lim CSE; Sengupta R; Gaffney K
Rheumatology (Oxford); 2018 Jun; 57(6):959-968. PubMed ID: 29029331
[TBL] [Abstract][Full Text] [Related]
19. Clinical profile and treatment utilisation based on HLA-B*27 status in axial spondyloarthritis: results from ASAS-PerSpA study.
Chaudhary H; López-Medina C; Khan MA; Dougados M; Magrey M
RMD Open; 2023 Jul; 9(3):. PubMed ID: 37491128
[TBL] [Abstract][Full Text] [Related]
20. Association of human leukocyte A, B, and DR antigens in Colombian patients with diagnosis of spondyloarthritis.
Santos AM; Peña P; Avila M; Briceño I; Jaramillo C; Vargas-Alarcon G; Rueda JC; Saldarriaga EL; Angarita JI; Martinez-Rodriguez N; Londono J
Clin Rheumatol; 2017 Apr; 36(4):953-958. PubMed ID: 28013432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
